INDIANAPOLIS, June 27, 2023 /PRNewswire/ -- Roche today announced that its Elecsys® beta-Amyloid (1-42) CSF II (Abeta42) and Elecsys ® Total-Tau CSF assays (tTau) have received U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results